Silica coating influences the corona and biokinetics of cerium oxide nanoparticles

Particle and Fibre Toxicology

Volumn 12, Issue 1, 2015, Pages

  Konduru, Nagarjun V ^a   Jimenez, Renato J ^a   Swami, Archana ^a   Friend, Sherri ^b   Castranova, Vincent ^c   Demokritou, Philip ^a   Brain, Joseph D ^a   Molina, Ramon M ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Bioavailability; Nanoceria; Protein corona; Silica

Indexed keywords

CERIUM 141; CERIUM OXIDE NANOPARTICLE; CORONA PROTEIN; LIPOPROTEIN; SILICON DIOXIDE; UNCLASSIFIED DRUG; CERIC OXIDE; CERIUM; METAL NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; INTESTINE ABSORPTION; LUNG CLEARANCE; LUNG LAVAGE; MALE; MATERIAL COATING; NEUTRON ACTIVATION ANALYSIS; NONHUMAN; PHYSICAL CHEMISTRY; PNEUMONIA; PRIORITY JOURNAL; PYROLYSIS; RAT; SYNTHESIS; ANIMAL; CHEMISTRY; ELECTRON MICROSCOPY; KINETICS; TISSUE DISTRIBUTION;

ANIMALS; CERIUM; KINETICS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON; RATS; SILICON DIOXIDE; TISSUE DISTRIBUTION;

EID: 84944067328     PISSN: 17438977     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/s12989-015-0106-4     Document Type: Article

References (69)

1. Bumajdad A, Eastoe J, Mathew A. Cerium oxide nanoparticles prepared in self-assembled systems. Adv Colloid Interface Sci. 2009;147-148:56-66.
2. Heckert EG, Seal S, Self WT. Fenton-like reaction catalyzed by the rare earth inner transition metal cerium. Environ Sci Technol. 2008;42:5014-9.
3. Karakoti AS, Munusamy P, Hostetler K, Kodali V, Kuchibhatla S, Orr G, et al. Preparation and Characterization Challenges to Understanding Environmental and Biological Impacts of Nanoparticles. Surf Interface Anal. 2012;44:882-9.
4. Karakoti AS, Singh S, Kumar A, Malinska M, Kuchibhatla SV, Wozniak K, et al. PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc. 2009;131:14144-5.
5. Baer DR. Surface Characterization of Nanoparticles: critical needs and significant challenges. J of Surface Anal. 2011;17:163-9.
6. Yokel RA, Hussain S, Garantziotis S, Demokritou P, Castranova V, Cassee FR. The Yin: An adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicity. Environ Sci Nano. 2014;1:406-28.
7. Chen J, Patil S, Seal S, McGinnis JF. Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat Nanotechnol. 2006;1:142-50.
8. Horie M, Nishio K, Kato H, Fujita K, Endoh S, Nakamura A, et al. Cellular responses induced by cerium oxide nanoparticles: induction of intracellular calcium level and oxidative stress on culture cells. J Biochem. 2011;150:461-71.
9. Ma JY, Mercer RR, Barger M, Schwegler-Berry D, Scabilloni J, Ma JK, et al. Induction of pulmonary fibrosis by cerium oxide nanoparticles. Toxicol Appl Pharmacol. 2012;262:255-64.
10. Srinivas A, Rao PJ, Selvam G, Murthy PB, Reddy PN. Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol Lett. 2011;205:105-15.
11. Colon J, Herrera L, Smith J, Patil S, Komanski C, Kupelian P, et al. Protection from radiation-induced pneumonitis using cerium oxide nanoparticles. Nanomedicine. 2009;5:225-31.
12. Colon J, Hsieh N, Ferguson A, Kupelian P, Seal S, Jenkins DW, et al. Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine. 2010;6:698-705.
13. Das S, Dowding JM, Klump KE, McGinnis JF, Self W, Seal S. Cerium oxide nanoparticles: applications and prospects in nanomedicine. Nanomedicine. 2013;8:1483-508.
14. Ma JY, Zhao H, Mercer RR, Barger M, Rao M, Meighan T, et al. Cerium oxide nanoparticle-induced pulmonary inflammation and alveolar macrophage functional change in rats. Nanotoxicology. 2011;5:312-25.
15. Molina RM, Konduru NV, Jimenez RJ, Pyrgiotakis G, Demokritou P, Wohlleben W, et al. Bioavailability, distribution and clearance of tracheally instilled, gavaged or injected cerium dioxide nanoparticles and ionic cerium. Environ Sci Nano. 2014;1:561-73.
16. Cohen J, Deloid G, Pyrgiotakis G, Demokritou P. Interactions of engineered nanomaterials in physiological media and implications for in vitro dosimetry. Nanotoxicology. 2013;7:417-31.
17. Pyrgiotakis G, Blattmann CO, Demokritou P. Real-Time Nanoparticle-Cell Interactions in Physiological Media by Atomic Force Microscopy. ACS Sustain Chem Eng. 2014;2:1681-90.
18. Pyrgiotakis G, Blattmann CO, Pratsinis S, Demokritou P. Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir. 2013;29:11385-95.
19. Wohlleben W, Ma-Hock L, Boyko V, Cox G, Egenolf H, Freiberger H, et al. Nanospecific guidance in REACH: A comparative physical-chemical characterization of 15 materials with methodical correlations. J Ceram Sci Tech. 2013;4:93-104.
20. Buzea C, Pacheco II, Robbie K. Nanomaterials and nanoparticles: sources and toxicity. Biointerphases. 2007;2:MR17-71.
21. Gass S, Cohen JM, Pyrgiotakis G, Sotiriou GA, Pratsinis SE, Demokritou P. A Safer Formulation Concept for Flame-Generated Engineered Nanomaterials. ACS Sustain Chem Eng. 2013;1:843-57.
22. Konduru NV, Murdaugh KM, Sotiriou GA, Donaghey TC, Demokritou P, Brain JD, et al. Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles. Part Fibre Toxicol. 2014;11:44.
23. Sotiriou GA, Watson C, Murdaugh KM, Darrah TH, Pyrgiotakis G, Elder A, et al. Engineering safer-by-design, transparent, silica-coated ZnO nanorods with reduced DNA damage potential. Environ Sci Nano. 2014;1:144-53.
24. Alwi R, Telenkov S, Mandelis A, Leshuk T, Gu F, Oladepo S, et al. Silica-coated super paramagnetic iron oxide nanoparticles (SPION) as biocompatible contrast agent in biomedical photoacoustics. Biomed Opt Express. 2012;3:2500-9.
25. Jana NR, Yu HH, Ali EM, Zheng Y, Ying JY. Controlled photostability of luminescent nanocrystalline ZnO solution for selective detection of aldehydes. Chem Commun. 2007;1406-1408.
26. Watson C, Ge J, Cohen J, Pyrgiotakis G, Engelward BP, Demokritou P. High-throughput screening platform for engineered nanoparticle-mediated genotoxicity using CometChip technology. ACS Nano. 2014;8:2118-33.
27. Warheit DB, McHugh TA, Hartsky MA. Differential pulmonary responses in rats inhaling crystalline, colloidal or amorphous silica dusts. Scand J Work Environ Health. 1995;21 Suppl 2:19-21.
28. 2 inhalation exposures. Nanotoxicology. 2013;7:1338-50.
29. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105:14265-70.
30. Geraets L, Oomen AG, Schroeter JD, Coleman VA, Cassee FR. Tissue distribution of inhaled micro- and nano-sized cerium oxide particles in rats: results from a 28-day exposure study. Toxicol Sci. 2012;127:463-73.
31. He X, Zhang H, Ma Y, Bai W, Zhang Z, Lu K, et al. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation. Nanotechnology. 2010;21:285103.
32. Yokel RA, Tseng MT, Dan M, Unrine JM, Graham UM, Wu P, et al. Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence. Nanomedicine. 2013;9:398-407.
33. Demokritou P, Buchel R, Molina RM, Deloid GM, Brain JD, Pratsinis SE. Development and characterization of a Versatile Engineered Nanomaterial Generation System (VENGES) suitable for toxicological studies. Inhal Toxicol. 2010;22 Suppl 2:107-16.
34. Ma J, Mercer RR, Barger M, Schwegler-Berry D, Cohen JM, Demokritou P, et al. Effects of amorphous silica coating on cerium oxide nanoparticles induced pulmonary responses. Toxicol Appl Pharmacol. 2015;288:63-73.
35. Brain JD, Knudson DE, Sorokin SP, Davis MA. Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ Res. 1976;11:13-33.
36. 2 films. Langmuir. 2008;24:12553-8.
37. Baisch BL, Corson NM, Wade-Mercer P, Gelein R, Kennell AJ, Oberdorster G, et al. Equivalent titanium dioxide nanoparticle deposition by intratracheal instillation and whole body inhalation: the effect of dose rate on acute respiratory tract inflammation. Part Fibre Toxicol. 2014;11:5.
38. Singh C, Friedrichs S, Ceccone G, Gibson N, Jensen KA, Levin M, et al. Cerium Dioxide, NM-211, NM-212, NM-213. Characterisation and test item preparation., JRC Repository: NM-series of Representative Manufactured Nanomaterials. Ispra, Italy: European Commission Joint Research Centre Institute for Health and Consumer Protection; 2014.
39. Bastacky J, Lee CY, Goerke J, Koushafar H, Yager D, Kenaga L, et al. Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol. 1995;79:1615-28.
40. Goerke J. Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta. 1998;1408:79-89.
41. Ruge CA, Schaefer UF, Herrmann J, Kirch J, Canadas O, Echaide M, et al. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One. 2012;7:e40775.
42. Schleh C, Hohlfeld JM. Interaction of nanoparticles with the pulmonary surfactant system. Inhal Toxicol. 2009;21 Suppl 1:97-103.
43. Cedervall T, Lynch I, Lindman S, Berggard T, Thulin E, Nilsson H, et al. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A. 2007;104:2050-5.
44. Milani S, Bombelli FB, Pitek AS, Dawson KA, Radler J. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano. 2012;6:2532-41.
45. Geiser M, Rothen-Rutishauser B, Kapp N, Schurch S, Kreyling W, Schulz H, et al. Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environ Health Perspect. 2005;113:1555-60.
46. Kim KJ, Malik AB. Protein transport across the lung epithelial barrier. Am J Physiol Lung Cell Mol Physiol. 2003;284:L247-59.
47. Berthiaume Y, Albertine KH, Grady M, Fick G, Matthay MA. Protein clearance from the air spaces and lungs of unanesthetized sheep over 144 h. J Appl Physiol. 1989;67:1887-97.
48. Choi HS, Ashitate Y, Lee JH, Kim SH, Matsui A, Insin N, et al. Rapid translocation of nanoparticles from the lung airspaces to the body. Nat Biotechnol. 2010;28:1300-3.
49. Pastva AM, Wright JR, Williams KL. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc. 2007;4:252-7.
50. Singer L, Colten HR, Wetsel RA. Complement C3 deficiency: human, animal, and experimental models. Pathobiology. 1994;62:14-28.
51. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol. 2005;5:58-68.
52. Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr CM. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm. 2011;77:376-83.
53. Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol. 2008;38:371-6.
54. Corrin B. Phagocytic potential of pulmonary alveolar epithelium with particular reference to surfactant metabolism. Thorax. 1970;25:110-5.
55. Brain JD, Bloom SB, Valberg PA, Gehr P. Correlation between the behavior of magnetic iron oxide particles in the lungs of rabbits and phagocytosis. Exp Lung Res. 1984;6:115-31.
56. 59iron oxide with alveolar macrophages during alveolar clearance. Exp Lung Res. 1985;9:1-16.
57. Clemens DL, Lee BY, Xue M, Thomas CR, Meng H, Ferris D, et al. Targeted intracellular delivery of antituberculosis drugs to Mycobacterium tuberculosis-infected macrophages via functionalized mesoporous silica nanoparticles. Antimicrob Agents Chemother. 2012;56:2535-45.
58. Dellinger A, Olson J, Link K, Vance S, Sandros MG, Yang J, et al. Functionalization of gadolinium metallofullerenes for detecting atherosclerotic plaque lesions by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2013;15:7.
59. Konduru NV, Tyurina YY, Feng W, Basova LV, Belikova NA, Bayir H, et al. Phosphatidylserine targets single-walled carbon nanotubes to professional phagocytes in vitro and in vivo. PLoS One. 2009;4, e4398.
60. Rollett A, Reiter T, Nogueira P, Cardinale M, Loureiro A, Gomes A, et al. Folic acid-functionalized human serum albumin nanocapsules for targeted drug delivery to chronically activated macrophages. Int J Pharm. 2012;427:460-6.
61. Park E-J, Park Y-K, Park K. Acute toxicity and tissue distribution of cerium oxide nanoparticles by a single oral administration in rats. Toxicol Res. 2009;25:79-84.
62. Brain JD, Molina RM, DeCamp MM, Warner AE. Pulmonary intravascular macrophages: their contribution to the mononuclear phagocyte system in 13 species. Am J Physiol. 1999;276:L146-54.
63. Vuarchey C, Kumar SRS. Albumin coated liposomes: a novel platform for macrophage specific drug delivery. Nanotechnol Dev. 2011;1:5-10.
64. Yokel RA, Au TC, MacPhail R, Hardas SS, Butterfield DA, Sultana R, et al. Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats. Toxicol Sci. 2012;127:256-68.
65. Beck BD, Brain JD, Bohannon DE. An in vivo hamster bioassay to assess the toxicity of particulates for the lungs. Toxicol Appl Pharmacol. 1982;66:9-29.
66. Brown RP, Delp MD, Lindstedt SL, Rhomberg LR, Beliles RP. Physiological parameter values for physiologically based pharmacokinetic models. Toxicol Ind Health. 1997;13:407-84.
67. Schoeffner DJ, Warren DA, Muralidara S, Bruckner JV, Simmons JE. Organ weights and fat volume in rats as a function of strain and age. J Toxicol Environ Health A. 1999;56:449-62.
68. Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem. 1996;68:850-8.
69. Peng J, Gygi SP. Proteomics: the move to mixtures. J Mass Spectrom. 2001;36:1083-91.